Perineuronal nets and schizophrenia: The importance of neuronal coatings

Neuroscience and Biobehavioral Reviews

Volumn 45, Issue , 2014, Pages 85-99

  Bitanihirwe, Byron K Y ^a   Woo, Tsung Ung W ^b,c,d  

^a UNIVERSITY OF ZURICH   (Switzerland)

^b MCLEAN HOSPITAL   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

^d BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

Neurodevelopment; Neuronal protection; Parvalbumin; Perineuronal nets; Schizophrenia; Synaptic connectivity; Synaptic plasticity

Indexed keywords

PHOSPHACAN; PROTEOGLYCAN; UNCLASSIFIED DRUG;

BEHAVIOR; CELL DENSITY; CELL MATURATION; CELLULAR DISTRIBUTION; EXTRACELLULAR MATRIX; GENE EXPRESSION; GENETIC MANIPULATION; HOMEOSTASIS; HUMAN; NERVE CELL PLASTICITY; NEUROPROTECTION; NONHUMAN; PATHOPHYSIOLOGY; PERINEURONAL NET; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; SCHIZOPHRENIA; SYNAPTIC MEMBRANE; ANIMAL; CENTRAL NERVOUS SYSTEM; GROWTH, DEVELOPMENT AND AGING; NERVE CELL; PHYSIOLOGY;

ANIMALS; CENTRAL NERVOUS SYSTEM; EXTRACELLULAR MATRIX; HUMANS; NEURONAL PLASTICITY; NEURONS; SCHIZOPHRENIA;

EID: 84902001430     PISSN: 01497634     EISSN: 18737528     Source Type: Journal    
DOI: 10.1016/j.neubiorev.2014.03.018     Document Type: Review

References (282)

1. Alpar A., Gartner U., Hartig W., Bruckner G. Distribution of pyramidal cells associated with perineuronal nets in the neocortex of rat. Brain Res. 2006, 1120:13-22.
2. Arseneault L., Cannon M., Witton J., Murray R.M. Causal association between cannabis and psychosis: examination of the evidence. Br. J. Psychiatry 2004, 184:110-117.
3. Atoji Y., Yamamoto Y., Suzuki Y., Matsui F., Oohira A. Immunohistochemical localization of neurocan in the lower auditory nuclei of the dog. Hear. Res. 1997, 110:200-208.
4. Baig S., Wilcock G.K., Love S. Loss of perineuronal net N-acetylgalactosamine in Alzheimer's disease. Acta Neuropathol. 2005, 110:393-401.
5. Balmer T.S., Carels V.M., Frisch J.L., Nick T.A. Modulation of perineuronal nets and parvalbumin with developmental song learning. J. Neurosci. 2009, 29:12878-12885.
6. Barros C.S., Franco S.J., Muller U. Extracellular matrix: functions in the nervous system. Cold Spring Harb. Perspect. Biol. 2011, 3:a005108.
7. Bartzokis G. Schizophrenia: breakdown in the well-regulated lifelong process of brain development and maturation. Neuropsychopharmacology 2002, 27:672-683.
8. Bartzokis G., Nuechterlein K.H., Lu P.H., Gitlin M., Rogers S., Mintz J. Dysregulated brain development in adult men with schizophrenia: a magnetic resonance imaging study. Biol. Psychiatry 2003, 53:412-421.
9. Basar-Eroglu C., Brand A., Hildebrandt H., Karolina Kedzior K., Mathes B., Schmiedt C. Working memory related gamma oscillations in schizophrenia patients. Int. J. Psychophysiol. 2007, 64:39-45.
10. Bavelier D., Levi D.M., Li R.W., Dan Y., Hensch T.K. Removing brakes on adult brain plasticity: from molecular to behavioral interventions. J. Neurosci. 2010, 30:14964-14971.
11. Bayer T.A., Buslei R., Havas L., Falkai P. Evidence for activation of microglia in patients with psychiatric illnesses. Neurosci. Lett. 1999, 271:126-128.
12. Bekku Y., Vargova L., Goto Y., Vorisek I., Dmytrenko L., Narasaki M., Ohtsuka A., Fassler R., Ninomiya Y., Sykova E., Oohashi T. Bral1: its role in diffusion barrier formation and conduction velocity in the CNS. J. Neurosci. 2010, 30:3113-3123.
13. Benes F.M. Myelination of cortical-hippocampal relays during late adolescence. Schizophr. Bull. 1989, 15:585-593.
14. Benes F.M. Emerging principles of altered neural circuitry in schizophrenia. Brain Res. Brain Res. Rev. 2000, 31:251-269.
15. Bentivoglio M., Mazzarello P. Chapter 12: the anatomical foundations of clinical neurology. Handb. Clin. Neurol. 2010, 95:149-168.
16. Bertolotto A., Rocca G., Canavese G., Migheli A., Schiffer D. Chondroitin sulfate proteoglycan surrounds a subset of human and rat CNS neurons. J. Neurosci. Res. 1991, 29:225-234.
17. Beurdeley M., Spatazza J., Lee H.H., Sugiyama S., Bernard C., Di Nardo A.A., Hensch T.K., Prochiantz A. Otx2 binding to perineuronal nets persistently regulates plasticity in the mature visual cortex. J. Neurosci. 2012, 32:9429-9437.
18. Bignami A., Hosley M., Dahl D. Hyaluronic acid and hyaluronic acid-binding proteins in brain extracellular matrix. Anat. Embryol. (Berl.) 1993, 188:419-433.
19. Bitanihirwe B.K., Lim M.P., Kelley J.F., Kaneko T., Woo T.U. Glutamatergic deficits and parvalbumin-containing inhibitory neurons in the prefrontal cortex in schizophrenia. BMC Psychiatry 2009, 9:71.
20. Bitanihirwe B.K., Peleg-Raibstein D., Mouttet F., Feldon J., Meyer U. Late prenatal immune activation in mice leads to behavioral and neurochemical abnormalities relevant to the negative symptoms of schizophrenia. Neuropsychopharmacology 2010, 35:2462-2478.
21. Bitanihirwe B.K., Woo T.U. Oxidative stress in schizophrenia: an integrated approach. Neurosci. Biobehav. Rev. 2011, 35:878-893.
22. Bradl M., Lassmann H. Oligodendrocytes: biology and pathology. Acta Neuropathol. 2010, 119:37-53.
23. Bradshaw N.J., Porteous D.J. DISC1-binding proteins in neural development, signalling and schizophrenia. Neuropharmacology 2012, 62:1230-1241.
24. Braff D.L. Information processing and attention dysfunctions in schizophrenia. Schizophr. Bull. 1993, 19:233-259.
25. Brandon N.J., Sawa A. Linking neurodevelopmental and synaptic theories of mental illness through DISC1. Nat. Rev. Neurosci. 2011, 12:707-722.
26. Brown A.S. The environment and susceptibility to schizophrenia. Prog. Neurobiol. 2011, 93:23-58.
27. Brown A.S. Epidemiologic studies of exposure to prenatal infection and risk of schizophrenia and autism. Dev. Neurobiol. 2012, 72:1272-1276.
28. Brown A.S., Derkits E.J. Prenatal infection and schizophrenia: a review of epidemiologic and translational studies. Am. J. Psychiatry 2010, 167:261-280.
29. Brown A.S., Susser E.S. In utero infection and adult schizophrenia. Ment. Retard. Dev. Disabil. Res. Rev. 2002, 8:51-57.
30. Bruckner G., Brauer K., Hartig W., Wolff J.R., Rickmann M.J., Derouiche A., Delpech B., Girard N., Oertel W.H., Reichenbach A. Perineuronal nets provide a polyanionic, glia-associated form of microenvironment around certain neurons in many parts of the rat brain. Glia 1993, 8:183-200.
31. Bruckner G., Bringmann A., Koppe G., Hartig W., Brauer K. In vivo and in vitro labelling of perineuronal nets in rat brain. Brain Res. 1996, 720:84-92.
32. Bruckner G., Grosche J., Schmidt S., Hartig W., Margolis R.U., Delpech B., Seidenbecher C.I., Czaniera R., Schachner M. Postnatal development of perineuronal nets in wild-type mice and in a mutant deficient in tenascin-R. J. Comp. Neurol. 2000, 428:616-629.
33. Bruckner G., Hartig W., Kacza J., Seeger J., Welt K., Brauer K. Extracellular matrix organization in various regions of rat brain grey matter. J. Neurocytol. 1996, 25:333-346.
34. Bruckner G., Hausen D., Hartig W., Drlicek M., Arendt T., Brauer K. Cortical areas abundant in extracellular matrix chondroitin sulphate proteoglycans are less affected by cytoskeletal changes in Alzheimer's disease. Neuroscience 1999, 92:791-805.
35. Bruckner G., Szeoke S., Pavlica S., Grosche J., Kacza J. Axon initial segment ensheathed by extracellular matrix in perineuronal nets. Neuroscience 2006, 138:365-375.
36. Budel S., Padukkavidana T., Liu B.P., Feng Z., Hu F., Johnson S., et al. Genetic variants of Nogo-66 receptor with possible association to schizophrenia block myelin inhibition of axon growth. J. Neurosci. 2008, 28:13161-13172.
37. Bukalo O., Schachner M., Dityatev A. Modification of extracellular matrix by enzymatic removal of chondroitin sulfate and by lack of tenascin-R differentially affects several forms of synaptic plasticity in the hippocampus. Neuroscience 2001, 104:359-369.
38. Buxbaum J.D., Georgieva L., Young J.J., Plescia C., Kajiwara Y., Jiang Y., Moskvina V., Norton N., Peirce T., Williams H., Craddock N.J., Carroll L., Corfas G., Davis K.L., Owen M.J., Harroch S., Sakurai T., O'Donovan M.C. Molecular dissection of NRG1-ERBB4 signaling implicates PTPRZ1 as a potential schizophrenia susceptibility gene. Mol. Psychiatry 2008, 13:162-172.
39. Buzsáki G. Rythms of the Brain 2006, Oxford University Press, New York.
40. Cabungcal J.H., Steullet P., Morishita H., Kraftsik R., Cuenod M., Hensch T.K., Do K.Q. Perineuronal nets protect fast-spiking interneurons against oxidative stress. Proc. Natl. Acad. Sci. U.S.A. 2013, 110:9130-9135.
41. Cannon M., Jones P.B., Murray R.M. Obstetric complications and schizophrenia: historical and meta-analytic review. Am. J. Psychiatry 2002, 159:1080-1092.
42. Cant N.B., Benson C.G. Wisteria floribunda lectin is associated with specific cell types in the ventral cochlear nucleus of the gerbil, Meriones unguiculatus. Hear. Res. 2006, 216-217:64-72.
43. Caroni P., Donato F., Muller D. Structural plasticity upon learning: regulation and functions. Nat. Rev. Neurosci. 2012, 13:478-490.
44. Carulli D., Pizzorusso T., Kwok J.C., Putignano E., Poli A., Forostyak S., Andrews M.R., Deepa S.S., Glant T.T., Fawcett J.W. Animals lacking link protein have attenuated perineuronal nets and persistent plasticity. Brain 2010, 133:2331-2347.
45. Casadio P., Fernandes C., Murray R.M., Di Forti M. Cannabis use in young people: the risk for schizophrenia. Neurosci. Biobehav. Rev. 2011, 35:1779-1787.
46. Celio M.R., Spreafico R., De Biasi S., Vitellaro-Zuccarello L. Perineuronal nets: past and present. Trends Neurosci. 1998, 21:510-515.
47. Cho R.Y., Konecky R.O., Carter C.S. Impairments in frontal cortical {gamma} synchrony and cognitive control in schizophrenia. Proc. Natl. Acad. Sci. U.S.A. 2006, 103:19878-19883.
48. Clarke M.C., Harley M., Cannon M. The role of obstetric events in schizophrenia. Schizophr. Bull. 2006, 32:3-8.
49. Daskalakis Z.J., Fitzgerald P.B., Christensen B.K. The role of cortical inhibition in the pathophysiology and treatment of schizophrenia. Brain Res. Rev. 2007, 56:427-442.
50. Deepa S.S., Carulli D., Galtrey C., Rhodes K., Fukuda J., Mikami T., Sugahara K., Fawcett J.W. Composition of perineuronal net extracellular matrix in rat brain: a different disaccharide composition for the net-associated proteoglycans. J. Biol. Chem. 2006, 281:17789-17800.
51. Dick G., Tan C.L., Alves J.N., Ehlert E.M., Miller G.M., Hsieh-Wilson L.C., Sugahara K., Oosterhof A., van Kuppevelt T.H., Verhaagen J., Fawcett J.W., Kwok J.C. Semaphorin 3A binds to the perineuronal nets via chondroitin sulfate type E motifs in rodent brains. J. Biol. Chem. 2013, 288:27384.
52. Dickendesher T.L., Baldwin K.T., Mironova Y.A., Koriyama Y., Raiker S.J., Askew K.L., Wood A., Geoffroy C.G., Zheng B., Liepmann C.D., Katagiri Y., Benowitz L.I., Geller H.M., Giger R.J. NgR1 and NgR3 are receptors for chondroitin sulfate proteoglycans. Nat. Neurosci. 2012, 15:703-712.
53. Dityatev A., Bruckner G., Dityateva G., Grosche J., Kleene R., Schachner M. Activity-dependent formation and functions of chondroitin sulfate-rich extracellular matrix of perineuronal nets. Dev. Neurobiol. 2007, 67:570-588.
54. Dityatev A., Schachner M. Extracellular matrix molecules and synaptic plasticity. Nat. Rev. Neurosci. 2003, 4:456-468.
55. Do K.Q., Cabungcal J.H., Frank A., Steullet P., Cuenod M. Redox dysregulation, neurodevelopment, and schizophrenia. Curr. Opin. Neurobiol. 2009, 19:220-230.
56. Dours-Zimmermann M.T., Maurer K., Rauch U., Stoffel W., Fassler R., Zimmermann D.R. Versican V2 assembles the extracellular matrix surrounding the nodes of ranvier in the CNS. J. Neurosci. 2009, 29:7731-7742.
57. Du J., Zhang L., Weiser M., Rudy B., McBain C.J. Developmental expression and functional characterization of the potassium-channel subunit Kv3.1b in parvalbumin-containing interneurons of the rat hippocampus. J. Neurosci. 1996, 16:506-518.
58. During D.N., Ziegler A., Thompson C.K., Faber C., Muller J., Scharff C., Elemans C.P. The songbird syrinx morphome: a three-dimensional, high-resolution, interactive morphological map of the zebra finch vocal organ. BMC Biol. 2013, 11:1.
59. Earls L.R., Zakharenko S.S. A synaptic function approach to investigating complex psychiatric diseases. Neuroscientist 2013, 20:257-271.
60. Eichhammer P., Wiegand R., Kharraz A., Langguth B., Binder H., Hajak G. Cortical excitability in neuroleptic-naive first-episode schizophrenic patients. Schizophr. Res. 2004, 67:253-259.
61. Franklin S.L., Love S., Greene J.R., Betmouni S. Loss of perineuronal net in ME7 prion disease. J. Neuropathol. Exp. Neurol. 2008, 67:189-199.
62. Farzan F., Barr M.S., Levinson A.J., Chen R., Wong W., Fitzgerald P.B., Daskalakis Z.J. Evidence for gamma inhibition deficits in the dorsolateral prefrontal cortex of patients with schizophrenia. Brain 2010, 133:1505-1514.
63. Feinberg I. Schizophrenia: caused by a fault in programmed synaptic elimination during adolescence. J. Psychiatr. Res. 1982, 17:319-334.
64. Franco S.J., Muller U. Extracellular matrix functions during neuronal migration and lamination in the mammalian central nervous system. Dev. Neurobiol. 2011, 71:889-900.
65. Frantz C., Stewart K.M., Weaver V.M. The extracellular matrix at a glance. J. Cell Sci. 2010, 123:4195-4200.
66. Friauf E. Development of chondroitin sulfate proteoglycans in the central auditory system of rats correlates with acquisition of mature properties. Audiol. Neurootol. 2000, 5:251-262.
67. Frith C.D. Consciousness, information processing and schizophrenia. Br. J. Psychiatry 1979, 134:225-235.
68. Fuxe K., Borroto-Escuela D.O., Romero-Fernandez W., Zhang W.B., Agnati L.F. Volume transmission and its different forms in the central nervous system. Chin. J. Integr. Med. 2013, 19:323-329.
69. Galtrey C.M., Fawcett J.W. The role of chondroitin sulfate proteoglycans in regeneration and plasticity in the central nervous system. Brain Res. Rev. 2007, 54:1-18.
70. Gan L., Kaczmarek L.K. When, where, and how much? Expression of the Kv3.1 potassium channel in high-frequency firing neurons. J. Neurobiol. 1998, 37:69-79.
71. Garwood J., Heck N., Reichardt F., Faissner A. Phosphacan short isoform, a novel non-proteoglycan variant of phosphacan/receptor protein tyrosine phosphatase-beta, interacts with neuronal receptors and promotes neurite outgrowth. J. Biol. Chem. 2003, 278:24164-24173.
72. Garwood J., Rigato F., Heck N., Faissner A. Tenascin glycoproteins and the complementary ligand DSD-1-PG/phosphacan - structuring the neural extracellular matrix during development and repair. Restor. Neurol. Neurosci. 2001, 19:51-64.
73. Georgiev D., Arion D., Enwright J.F., Kikuchi M., Minabe Y., Corradi J.P., Lewis D.A., Hashimoto T. Lower gene expression for KCNS3 potassium channel subunit in parvalbumin-containing neurons in the prefrontal cortex in schizophrenia. Am. J. Psychiatry 2014, 171:62-71.
74. Georgiev D., Gonzalez-Burgos G., Kikuchi M., Minabe Y., Lewis D.A., Hashimoto T. Selective expression of KCNS3 potassium channel alpha-subunit in parvalbumin-containing GABA neurons in the human prefrontal cortex. PLoS ONE 2012, 7:e43904.
75. Gerlinger G., Hauser M., De Hert M., Lacluyse K., Wampers M., Correll C.U. Personal stigma in schizophrenia spectrum disorders: a systematic review of prevalence rates, correlates, impact and interventions. World Psychiatry 2013, 12:155-164.
76. Gherardini L., Gennaro M., Pizzorusso T. Perilesional treatment with chondroitinase ABC and motor training promote functional recovery after stroke in rats. Cereb. Cortex 2013, (Epub ahead of print).
77. Giamanco K.A., Morawski M., Matthews R.T. Perineuronal net formation and structure in aggrecan knockout mice. Neuroscience 2010, 170:1314-1327.
78. Giovanoli S., Engler H., Engler A., Richetto J., Voget M., Willi R., Winter C., Riva M.A., Mortensen P.B., Schedlowski M., Meyer U. Stress in puberty unmasks latent neuropathological consequences of prenatal immune activation in mice. Science 2013, 339:1095-1099.
79. Glantz L.A., Lewis D.A. Reduction of synaptophysin immunoreactivity in the prefrontal cortex of subjects with schizophrenia. Regional and diagnostic specificity. Arch. Gen. Psychiatry 1997, 54:660-669.
80. Glantz L.A., Lewis D.A. Decreased dendritic spine density on prefrontal cortical pyramidal neurons in schizophrenia. Arch. Gen. Psychiatry 2000, 57:65-73.
81. Gogolla N., Caroni P., Luthi A., Herry C. Perineuronal nets protect fear memories from erasure. Science 2009, 325:1258-1261.
82. Goldman-Rakic P.S. Working memory dysfunction in schizophrenia. J. Neuropsychiatry Clin. Neurosci. 1994, 6:348-357.
83. Golgi C. Intorno alla struttura delle cellule nervose. Boll. Soc. Med. Chir. Pavia 1898, 13:1-14.
84. Gonzalez-Burgos G., Hashimoto T., Lewis D.A. Alterations of cortical GABA neurons and network oscillations in schizophrenia. Curr. Psychiatry Rep. 2010, 12:335-344.
85. Gonzalez-Burgos G., Lewis D.A. GABA neurons and the mechanisms of network oscillations: implications for understanding cortical dysfunction in schizophrenia. Schizophr. Bull. 2008, 34:944-961.
86. Gray E., Thomas T.L., Betmouni S., Scolding N., Love S. Elevated matrix metalloproteinase-9 and degradation of perineuronal nets in cerebrocortical multiple sclerosis plaques. J. Neuropathol. Exp. Neurol. 2008, 67:888-899.
87. Gray C.M., Engel A.K., König P., Singer W. Synchronization of oscillatory neuronal responses in cat striate cortex: temporal properties. Vis. Neurosci. 1992, 8:337-347.
88. Grutzner C., Wibral M., Sun L., Rivolta D., Singer W., Maurer K., Uhlhaas P.J. Deficits in high- (>60Hz) gamma-band oscillations during visual processing in schizophrenia. Front. Hum. Neurosci. 2013, 7:88.
89. Guentchev M., Wanschitz J., Voigtländer T., Flicker H., Budka H. Selective neuronal vulnerability in human prion diseases. Fatal familial insomnia differs from other types of prion diseases. Am. J. Pathol. 1999, 155:1453-1457.
90. Guimaraes A., Zaremba S., Hockfield S. Molecular and morphological changes in the cat lateral geniculate nucleus and visual cortex induced by visual deprivation are revealed by monoclonal antibodies Cat-304 and Cat-301. J. Neurosci. 1990, 10:3014-3024.
91. Harrison P.J. Postmortem studies in schizophrenia. Dialogues Clin. Neurosci. 2000, 2:349-357.
92. Harrison P.J., Weinberger D.R. Schizophrenia genes, gene expression, and neuropathology: on the matter of their convergence. Mol. Psychiatry 2005, 10:40-68. (Image 45).
93. Harroch S., Palmeri M., Rosenbluth J., Custer A., Okigaki M., Shrager P., Blum M., Buxbaum J.D., Schlessinger J. No obvious abnormality in mice deficient in receptor protein tyrosine phosphatase beta. Mol. Cell. Biol. 2000, 20:7706-7715.
94. Hartig W., Brauer K., Bigl V., Bruckner G. Chondroitin sulfate proteoglycan-immunoreactivity of lectin-labeled perineuronal nets around parvalbumin-containing neurons. Brain Res. 1994, 635:307-311.
95. Hartig W., Brauer K., Bruckner G. Wisteria floribunda agglutinin-labelled nets surround parvalbumin-containing neurons. Neuroreport 1992, 3:869-872.
96. Hartig W., Derouiche A., Welt K., Brauer K., Grosche J., Mader M., Reichenbach A., Bruckner G. Cortical neurons immunoreactive for the potassium channel Kv3.1b subunit are predominantly surrounded by perineuronal nets presumed as a buffering system for cations. Brain Res. 1999, 842:15-29.
97. Hartig W., Singer A., Grosche J., Brauer K., Ottersen O.P., Bruckner G. Perineuronal nets in the rat medial nucleus of the trapezoid body surround neurons immunoreactive for various amino acids, calcium-binding proteins and the potassium channel subunit Kv3.1b. Brain Res. 2001, 899:123-133.
98. Hashimoto T., Volk D.W., Eggan S.M., Mirnics K., Pierri J.N., Sun Z., Sampson A.R., Lewis D.A. Gene expression deficits in a subclass of GABA neurons in the prefrontal cortex of subjects with schizophrenia. J. Neurosci. 2003, 23:6315-6326.
99. Haunso A., Celio M.R., Margolis R.K., Menoud P.A. Phosphacan immunoreactivity is associated with perineuronal nets around parvalbumin-expressing neurones. Brain Res. 1999, 834:219-222.
100. Hausen D., Bruckner G., Drlicek M., Hartig W., Brauer K., Bigl V. Pyramidal cells ensheathed by perineuronal nets in human motor and somatosensory cortex. Neuroreport 1996, 7:1725-1729.
101. Henquet C., Murray R., Linszen D., van Os J. The environment and schizophrenia: the role of cannabis use. Schizophr. Bull. 2005, 31:608-612.
102. Hensch T.K. Critical period mechanisms in developing visual cortex. Curr. Top. Dev. Biol. 2005, 69:215-237.
103. Hensch T.K. Critical period plasticity in local cortical circuits. Nat. Rev. Neurosci. 2005, 6:877-888.
104. Quirk G.J., Paré D., Richardson R., Herry C., Monfils M.H., Schiller D., Vicentic A. Erasing fear memories with extinction training. J. Neurosci. 2010, 30:14993-14997.
105. Hilbig H., Nowack S., Boeckler K., Bidmon H.J., Zilles K. Characterization of neuronal subsets surrounded by perineuronal nets in the rhesus auditory brainstem. J. Anat. 2007, 210:507-517.
106. Hobohm C., Hartig W., Brauer K., Bruckner G. Low expression of extracellular matrix components in rat brain stem regions containing modulatory aminergic neurons. J. Chem. Neuroanat. 1998, 15:135-142.
107. Hobohm C., Günther A., Grosche J., Rossner S., Schneider D., Brückner G. Decomposition and long-lasting downregulation of extracellular matrix in perineuronal nets induced by focal cerebral ischemia in rats. J. Neurosci. Res. 2005, 80:539-548.
108. Hockfield S., Kalb R.G., Zaremba S., Fryer H. Expression of neural proteoglycans correlates with the acquisition of mature neuronal properties in the mammalian brain. Cold Spring Harb. Symp. Quant. Biol. 1990, 55:505-514.
109. Hoffman R.E., Hawkins K.A., Gueorguieva R., Boutros N.N., Rachid F., Carroll K., Krystal J.H. Transcranial magnetic stimulation of left temporoparietal cortex and medication-resistant auditory hallucinations. Arch. Gen. Psychiatry 2003, 60:49-56.
110. Hoffman R.E., Cavus I. Slow transcranial magnetic stimulation, long-term depotentiation, and brain hyperexcitability disorders. Am. J. Psychiatry 2002, 159:1093-1102.
111. Hoistad M., Segal D., Takahashi N., Sakurai T., Buxbaum J.D., Hof P.R. Linking white and grey matter in schizophrenia: oligodendrocyte and neuron pathology in the prefrontal cortex. Front. Neuroanat. 2009, 3:9.
112. Howes O.D., Kapur S. The dopamine hypothesis of schizophrenia: version III - the final common pathway. Schizophr. Bull. 2009, 35:549-562.
113. Juckel G., Manitz M.P., Brune M., Friebe A., Heneka M.T., Wolf R.J. Microglial activation in a neuroinflammational animal model of schizophrenia - a pilot study. Schizophr. Res. 2011, 131:96-100.
114. Kahler A.K., Djurovic S., Rimol L.M., Brown A.A., Athanasiu L., Jonsson E.G., Hansen T., Gustafsson O., Hall H., Giegling I., Muglia P., Cichon S., Rietschel M., Pietilainen O.P., Peltonen L., Bramon E., Collier D., St Clair D., Sigurdsson E., Petursson H., Rujescu D., Melle I., Werge T., Steen V.M., Dale A.M., Matthews R.T., Agartz I., Andreassen O.A. Candidate gene analysis of the human natural killer-1 carbohydrate pathway and perineuronal nets in schizophrenia: B3GAT2 is associated with disease risk and cortical surface area. Biol. Psychiatry 2011, 69:90-96.
115. Kalb R.G., Hockfield S. Molecular evidence for early activity-dependent development of hamster motor neurons. J. Neurosci. 1988, 8:2350-2360.
116. Kalb R.G., Hockfield S. Induction of a neuronal proteoglycan by the NMDA receptor in the developing spinal cord. Science 1990, 250:294-296.
117. Kalb R.G., Hockfield S. Large diameter primary afferent input is required for expression of the Cat-301 proteoglycan on the surface of motor neurons. Neuroscience 1990, 34:391-401.
118. Karayiorgou M., Simon T.J., Gogos J.A. 22q11.2 microdeletions: linking DNA structural variation to brain dysfunction and schizophrenia. Nat. Rev. Neurosci. 2010, 11:402-416.
119. Karetko M., Skangiel-Kramska J. Diverse functions of perineuronal nets. Acta Neurobiol. Exp. (Wars.) 2009, 69:564-577.
120. Kelsch W., Sim S., Lois C. Watching synaptogenesis in the adult brain. Annu. Rev. Neurosci. 2010, 33:131-149.
121. Keshavan M.S., Anderson S., Pettegrew J.W. Is schizophrenia due to excessive synaptic pruning in the prefrontal cortex? The Feinberg hypothesis revisited. J. Psychiatr. Res. 1994, 28:239-265.
122. Kind P.C., Beaver C.J., Mitchell D.E. Effects of early periods of monocular deprivation and reverse lid suture on the development of Cat-301 immunoreactivity in the dorsal lateral geniculate nucleus (dLGN) of the cat. J. Comp. Neurol. 1995, 359:523-536.
123. Kirihara K., Rissling A.J., Swerdlow N.R., Braff D.L., Light G.A. Hierarchical organization of gamma and theta oscillatory dynamics in schizophrenia. Biol. Psychiatry 2012, 71:873-880.
124. Kirkbride J.B., Errazuriz A., Croudace T.J., Morgan C., Jackson D., Boydell J., Murray R.M., Jones P.B. Incidence of schizophrenia and other psychoses in England, 1950-2009: a systematic review and meta-analyses. PLoS ONE 2012, 7:e31660.
125. Kobayashi K., Emson P.C., Mountjoy C.Q. Vicia villosa lectin-positive neurones in human cerebral cortex. Loss in Alzheimer-type dementia. Brain Res. 1989, 498:170-174.
126. Kohen R., Nyska A. Oxidation of biological systems: oxidative stress phenomena, antioxidants, redox reactions, and methods for their quantification. Toxicol. Pathol. 2002, 30:620-650.
127. Kumari V., Soni W., Sharma T. Normalization of information processing deficits in schizophrenia with clozapine. Am. J. Psychiatry 1999, 156:1046-1051.
128. Kwok J.C., Afshari F., Garcia-Alias G., Fawcett J.W. Proteoglycans in the central nervous system: plasticity, regeneration and their stimulation with chondroitinase ABC. Restor. Neurol. Neurosci. 2008, 26:131-145.
129. Kwok J.C., Dick G., Wang D., Fawcett J.W. Extracellular matrix and perineuronal nets in CNS repair. Dev. Neurobiol. 2011, 71:1073-1089.
130. Lakatos P., Schroeder C.E., Leitman D.I., Javitt D.C. Predictive suppression of cortical excitability and its deficit in schizophrenia. J. Neurosci. 2013, 33:11692-11702.
131. Lander C., Kind P., Maleski M., Hockfield S. A family of activity-dependent neuronal cell-surface chondroitin sulfate proteoglycans in cat visual cortex. J. Neurosci. 1997, 17:1928-1939.
132. Lau L.W., Cua R., Keough M.B., Haylock-Jacobs S., Yong V.W. Pathophysiology of the brain extracellular matrix: a new target for remyelination. Nat. Rev. Neurosci. 2013, 14:722-729.
133. Lee H., Leamey C.A., Sawatari A. Perineuronal nets play a role in regulating striatal function in the mouse. PLoS ONE 2012, 7:e32747.
134. Lee H., Sawatari A. Medium spiny neurons of the neostriatal matrix exhibit specific, stereotyped changes in dendritic arborization during a critical developmental period in mice. Eur. J. Neurosci. 2011, 34:1345-1354.
135. Lendvai D., Morawski M., Negyessy L., Gati G., Jager C., Baksa G., Glasz T., Attems J., Tanila H., Arendt T., Harkany T., Alpar A. Neurochemical mapping of the human hippocampus reveals perisynaptic matrix around functional synapses in Alzheimer's disease. Acta Neuropathol. 2013, 125:215-229.
136. Lenz S., Perney T.M., Qin Y., Robbins E., Chesselet M.F. GABA-ergic interneurons of the striatum express the Shaw-like potassium channel Kv3.1. Synapse 1994, 18:55-66.
137. Lewis D.A., Hashimoto T., Volk D.W. Cortical inhibitory neurons and schizophrenia. Nat. Rev. Neurosci. 2005, 6:312-324.
138. Liu H., Xu H., Yu T., Yao J., Zhao C., Yin Z.Q. Expression of perineuronal nets, parvalbumin and protein tyrosine phosphatase σ in the rat visual cortex during development and after BFD. Curr. Eye Res. 2013, 38:1083-1094.
139. Lora A., Kohn R., Levav I., McBain R., Morris J., Saxena S. Service availability and utilization and treatment gap for schizophrenic disorders: a survey in 50 low- and middle-income countries. Bull. World Health Organ. 2012, 90:47-54. 54A-54B.
140. Lumey L.H., Stein A.D., Susser E. Prenatal famine and adult health. Annu. Rev. Public Health 2011, 32:237-262.
141. Maeda N., Nishiwaki T., Shintani T., Hamanaka H., Noda M. 6B4 proteoglycan/phosphacan, an extracellular variant of receptor-like protein-tyrosine phosphatase zeta/RPTPbeta, binds pleiotrophin/heparin-binding growth-associated molecule (HB-GAM). J. Biol. Chem. 1996, 271:21446-21452.
142. Maren S., Phan K.L., Liberzon I. The contextual brain: implications for fear conditioning, extinction and psychopathology. Nat. Rev. Neurosci. 2013, 14:417-428.
143. Margari F., Petruzzelli M.G., Lecce P.A., Todarello O., De Giacomo A., Lucarelli E., Martinelli D., Margari L. Familial liability, obstetric complications and childhood development abnormalities in early onset schizophrenia: a case control study. BMC Psychiatry 2011, 11:60.
144. Margolis R.K., Margolis R.U. Nervous tissue proteoglycans. Experientia 1993, 49:429-446.
145. Margolis R.U., Margolis R.K. Chondroitin sulfate proteoglycans as mediators of axon growth and pathfinding. Cell Tissue Res. 1997, 290:343-348.
146. Martins-de-Souza D. Proteome and transcriptome analysis suggests oligodendrocyte dysfunction in schizophrenia. J. Psychiatr. Res. 2010, 44:149-156.
147. Martins-de-Souza D., Gattaz W.F., Schmitt A., Maccarrone G., Hunyadi-Gulyas E., Eberlin M.N., Souza G.H., Marangoni S., Novello J.C., Turck C.W., Dias-Neto E. Proteomic analysis of dorsolateral prefrontal cortex indicates the involvement of cytoskeleton, oligodendrocyte, energy metabolism and new potential markers in schizophrenia. J. Psychiatr. Res. 2009, 43:978-986.
148. Mataga N., Mizuguchi Y., Hensch T.K. Experience-dependent pruning of dendritic spines in visual cortex by tissue plasminogen activator. Neuron 2004, 44:1031-1041.
149. Mataga N., Nagai N., Hensch T.K. Permissive proteolytic activity for visual cortical plasticity. Proc. Natl. Acad. Sci. U.S.A. 2002, 99:7717-7721.
150. Mauney S.A., Athanas K.M., Pantazopoulos H., Shaskan N., Passeri E., Berretta S., Woo T.U. Developmental pattern of perineuronal nets in the human prefrontal cortex and their deficit in schizophrenia. Biol. Psychiatry 2013, 74:427-435.
151. Mayer J., Hamel M.G., Gottschall P.E. Evidence for proteolytic cleavage of brevican by the ADAMTSs in the dentate gyrus after excitotoxic lesion of the mouse entorhinal cortex. BMC Neurosci. 2005, 6:52.
152. McGlashan T.H., Hoffman R.E. Schizophrenia as a disorder of developmentally reduced synaptic connectivity. Arch. Gen. Psychiatry 2000, 57:637-648.
153. McGrath J., Saha S., Welham J., El Saadi O., MacCauley C., Chant D. A systematic review of the incidence of schizophrenia: the distribution of rates and the influence of sex, urbanicity, migrant status and methodology. BMC Med. 2004, 2:13.
154. McGrath J.J., Susser E.S. New directions in the epidemiology of schizophrenia. Med. J. Aust. 2009, 190:S7-S9.
155. McRae P.A., Porter B.E. The perineuronal net component of the extracellular matrix in plasticity and epilepsy. Neurochem. Int. 2012, 61:963-972.
156. McRae P.A., Rocco M.M., Kelly G., Brumberg J.C., Matthews R.T. Sensory deprivation alters aggrecan and perineuronal net expression in the mouse barrel cortex. J. Neurosci. 2007, 27:5405-5413.
157. Meyer U., Feldon J., Yee B.K. A review of the fetal brain cytokine imbalance hypothesis of schizophrenia. Schizophr. Bull. 2009, 35:959-972.
158. Meyer U. Prenatal poly(i:C) exposure and other developmental immune activation models in rodent systems. Biol. Psychiatry 2014, 75:307-315.
159. Ming G.L., Song H. Adult neurogenesis in the mammalian brain: significant answers and significant questions. Neuron 2011, 70:687-702.
160. Miyata S., Komatsu Y., Yoshimura Y., Taya C., Kitagawa H. Persistent cortical plasticity by upregulation of chondroitin 6-sulfation. Nat. Neurosci. 2012, 15:414-422. S411-S412.
161. Monji A., Kato T., Kanba S. Cytokines and schizophrenia: microglia hypothesis of schizophrenia. Psychiatry Clin. Neurosci. 2009, 63:257-265.
162. Morawski M., Alpar A., Bruckner G., Fiedler A., Jager C., Gati G., Stieler J.T., Arendt T. Chondroitin sulfate proteoglycan-based extracellular matrix in chicken (Gallus domesticus) brain. Brain Res. 2009, 1275:10-23.
163. Morawski M., Bruckner G., Jager C., Seeger G., Arendt T. Neurons associated with aggrecan-based perineuronal nets are protected against tau pathology in subcortical regions in Alzheimer's disease. Neuroscience 2010, 169:1347-1363.
164. Morawski M., Bruckner G., Jager C., Seeger G., Matthews R.T., Arendt T. Involvement of perineuronal and perisynaptic extracellular matrix in Alzheimer's disease neuropathology. Brain Pathol. 2012, 22:547-561.
165. Morawski M., Bruckner M.K., Riederer P., Bruckner G., Arendt T. Perineuronal nets potentially protect against oxidative stress. Exp. Neurol. 2004, 188:309-315.
166. Morris N.P., Henderson Z. Perineuronal nets ensheath fast spiking, parvalbumin-immunoreactive neurons in the medial septum/diagonal band complex. Eur. J. Neurosci. 2000, 12:828-838.
167. Morris R. Developments of a water-maze procedure for studying spatial learning in the rat. J. Neurosci. Methods 1984, 11:47-60.
168. Muhleisen T.W., Mattheisen M., Strohmaier J., Degenhardt F., Priebe L., Schultz C.C., Breuer R., Meier S., Hoffmann P., Rivandeneira F., Hofman A., Uitterlinden A.G., Moebus S., Gieger C., Emeny R., Ladwig K.H., Wichmann H.E., Schwarz M., Kammerer-Ciernioch J., Schlosser R.G., Nenadic I., Sauer H., Mossner R., Maier W., Rujescu D., Lange C., Ophoff R.A., Schulze T.G., Rietschel M., Nothen M.M., Cichon S. Association between schizophrenia and common variation in neurocan (NCAN), a genetic risk factor for bipolar disorder. Schizophr. Res. 2012, 138:69-73.
169. Muir E.M., Adcock K.H., Morgenstern D.A., Clayton R., von Stillfried N., Rhodes K., Ellis C., Fawcett J.W., Rogers J.H. Matrix metalloproteases and their inhibitors are produced by overlapping populations of activated astrocytes. Brain Res. Mol. Brain Res. 2002, 100:103-117.
170. Murai K.K., Misner D., Ranscht B. Contactin supports synaptic plasticity associated with hippocampal long-term depression but not potentiation. Curr. Biol. 2002, 12:181-190.
171. Murakami T., Ohtsuka A., Taguchi T. Neurons with intensely negatively charged extracellular matrix in the human visual cortex. Arch. Histol. Cytol. 1994, 57:509-522.
172. Murray R.M., Lewis S.W. Is schizophrenia a neurodevelopmental disorder?. Br. Med. J. (Clin. Res. Ed.) 1987, 295:681-682.
173. Nabel E.M., Morishita H. Regulating critical period plasticity: insight from the visual system to fear circuitry for therapeutic interventions. Front. Psychiatry 2013, 4:146.
174. Najjar S., Pearlman D.M., Alper K., Najjar A., Devinsky O. Neuroinflammation and psychiatric illness. J. Neuroinflamm. 2013, 10:43.
175. Nakagawa F., Schulte B.A., Spicer S.S. Selective cytochemical demonstration of glycoconjugate-containing terminal N-acetylgalactosamine on some brain neurons. J. Comp. Neurol. 1986, 243:280-290.
176. Nakamura M., Nakano K., Morita S., Nakashima T., Oohira A., Miyata S. Expression of chondroitin sulfate proteoglycans in barrel field of mouse and rat somatosensory cortex. Brain Res. 2009, 1252:117-129.
177. Narayan S., Nakajima K., Sawa A. DISC1: a key lead in studying cortical development and associated brain disorders. Neuroscientist 2013, 19:451-464.
178. Nicodemus K.K., Marenco S., Batten A.J., Vakkalanka R., Egan M.F., Straub R.E., Weinberger D.R. Serious obstetric complications interact with hypoxia-regulated/vascular-expression genes to influence schizophrenia risk. Mol. Psychiatry 2008, 13:873-877.
179. Novak U., Kaye A.H. Extracellular matrix and the brain: components and function. J. Clin. Neurosci. 2000, 7:280-290.
180. Nowicka D., Soulsby S., Skangiel-Kramska J., Glazewski S. Parvalbumin-containing neurons, perineuronal nets and experience-dependent plasticity in murine barrel cortex. Eur. J. Neurosci. 2009, 30:2053-2063.
181. Nyffeler M., Meyer U., Yee B.K., Feldon J., Knuesel I. Maternal immune activation during pregnancy increases limbic GABAA receptor immunoreactivity in the adult offspring: implications for schizophrenia. Neuroscience 2006, 143:51-62.
182. Ohi K., Hashimoto R., Yamamori H., Yasuda Y., Fujimoto M., Umeda-Yano S., Fukunaga M., Watanabe Y., Iwase M., Kazui H., Takeda M. The impact of the genome-wide supported variant in the cyclin M2 gene on gray matter morphology in schizophrenia. Behav. Brain Funct. BBF 2013, 9:40.
183. Ojima H., Kuroda M., Ohyama J., Kishi K. Two classes of cortical neurones labelled with Vicia villosa lectin in the guinea-pig. Neuroreport 1995, 6:617-620.
184. Omori Y., Mori C., White A.H. Self-stigma in schizophrenia: a concept analysis. Nurs. Forum 2014, (Epub ahead of print).
185. Orlando C., Ster J., Gerber U., Fawcett J.W., Raineteau O. Perisynaptic chondroitin sulfate proteoglycans restrict structural plasticity in an integrin-dependent manner. J. Neurosci. 2012, 32:18009-18017.
186. Pantazopoulos H., Boyer-Boiteau A., Holbrook E.H., Jang W., Hahn C.G., Arnold S.E., Berretta S. Proteoglycan abnormalities in olfactory epithelium tissue from subjects diagnosed with schizophrenia. Schizophr. Res. 2013, 150:366-372.
187. Pantazopoulos H., Murray E.A., Berretta S. Total number, distribution, and phenotype of cells expressing chondroitin sulfate proteoglycans in the normal human amygdala. Brain Res. 2008, 1207:84-95.
188. Pantazopoulos H., Woo T.-U.W., Lim M.P., Lange N., Berretta S. Extracellular matrix-glial abnormalities in the amygdala and entorhinal cortex of subjects diagnosed with schizophrenia. Arch. Gen. Psychiatry 2010, 67:155-166.
189. Pare D., Duvarci S. Amygdala microcircuits mediating fear expression and extinction. Curr. Opin. Neurobiol. 2012, 22:717-723.
190. Perala J., Suvisaari J., Saarni S.I., Kuoppasalmi K., Isometsa E., Pirkola S., Partonen T., Tuulio-Henriksson A., Hintikka J., Kieseppa T., Harkanen T., Koskinen S., Lonnqvist J. Lifetime prevalence of psychotic and bipolar I disorders in a general population. Arch. Gen. Psychiatry 2007, 64:19-28.
191. Perney T.M., Marshall J., Martin K.A., Hockfield S., Kaczmarek L.K. Expression of the mRNAs for the Kv3.1 potassium channel gene in the adult and developing rat brain. J. Neurophysiol. 1992, 68:756-766.
192. Perry W., Feifel D., Minassian A., Bhattacharjie I., Braff D.L. Information processing deficits in acutely psychotic schizophrenia patients medicated and unmedicated at the time of admission. Am. J. Psychiatry 2002, 159:1375-1381.
193. Phelan J.C., Bromet E.J., Link B.G. Psychiatric illness and family stigma. Schizophr. Bull. 1998, 24:115-126.
194. Pietersen C.Y., Mauney S.A., Kim S.S., Lim M.P., Rooney R.J., Goldstein J.M., Petryshen T.L., Seidman L.J., Shenton M.E., McCarley R.W., Sonntag K.C., Woo T.U.W. Molecular profiles of parvalbumin-immunoreactive neurons in the superior temporal cortex in schizophrenia. J. Neurogenet. 2014, (in press).
195. Pietersen C.Y., Mauney S.A., Kim S.S., Lim M.P., Rooney R.J., Goldstein J.M., Petryshen T.L., Seidman L.J., Shenton M.E., McCarley R.W., Sonntag K.C., Woo T.U.W. Molecular profiles of pyramidal neurons in the superior temporal cortex in schizophrenia. J. Neurogenet. 2014, (in press).
196. Pizzorusso T., Medini P., Berardi N., Chierzi S., Fawcett J.W., Maffei L. Reactivation of ocular dominance plasticity in the adult visual cortex. Science 2002, 298:1248-1251.
197. Pizzorusso T., Medini P., Landi S., Baldini S., Berardi N., Maffei L. Structural and functional recovery from early monocular deprivation in adult rats. Proc. Natl. Acad. Sci. U.S.A. 2006, 103:8517-8522.
198. Poliak S., Peles E. The local differentiation of myelinated axons at nodes of Ranvier. Nat. Rev. Neurosci. 2003, 4:968-980.
199. Radewicz K., Garey L.J., Gentleman S.M., Reynolds R. Increase in HLA-DR immunoreactive microglia in frontal and temporal cortex of chronic schizophrenics. J. Neuropathol. Exp. Neurol. 2000, 59:137-150.
200. Rauch U. Extracellular matrix components associated with remodeling processes in brain. Cell. Mol. Life Sci. 2004, CMLS 61:2031-2045.
201. Richetto J., Calabrese F., Meyer U., Riva M.A. Prenatal versus postnatal maternal factors in the development of infection-induced working memory impairments in mice. Brain Behav. Immun. 2013, 33:190-200.
202. Ripke S., O'Dushlaine C., Chambert K., Moran J.L., Kähler A.K., Akterin S., Bergen S.E., Collins A.L., Crowley J.J., Fromer M., Kim Y., Lee S.H., Magnusson P.K., et al. Genome-wide association analysis identifies 13 new risk loci for schizophrenia. Nat. Genet. 2013, 45:1150-1159.
203. Rissling A.J., Braff D.L., Swerdlow N.R., Hellemann G., Rassovsky Y., Sprock J., Pela M., Light G.A. Disentangling early sensory information processing deficits in schizophrenia. Clin. Neurophysiol. 2012, 123:1942-1949.
204. Roberts R.A., Smith R.A., Safe S., Szabo C., Tjalkens R.B., Robertson F.M. Toxicological and pathophysiological roles of reactive oxygen and nitrogen species. Toxicology 2010, 276:85-94.
205. Roberts R.A., Laskin D.L., Smith C.V., Robertson F.M., Allen E.M., Doorn J.A., Slikker W. Nitrative and oxidative stress in toxicology and disease. Toxicol. Sci. 2009, 112:4-16.
206. Romberg C., Yang S., Melani R., Andrews M.R., Horner A.E., Spillantini M.G., Bussey T.J., Fawcett J.W., Pizzorusso T., Saksida L.M. Depletion of perineuronal nets enhances recognition memory and long-term depression in the perirhinal cortex. J. Neurosci. 2013, 33:7057-7065.
207. Roussos P., Katsel P., Davis K.L., Bitsios P., Giakoumaki S.G., Jogia J., Rozsnyai K., Collier D., Frangou S., Siever L.J., Haroutunian V. Molecular and genetic evidence for abnormalities in the nodes of Ranvier in schizophrenia. Arch. Gen. Psychiatry 2012, 69:7-15.
208. Ruoslahti E. Brain extracellular matrix. Glycobiology 1996, 6:489-492.
209. Saghatelyan A.K., Dityatev A., Schmidt S., Schuster T., Bartsch U., Schachner M. Reduced perisomatic inhibition, increased excitatory transmission, and impaired long-term potentiation in mice deficient for the extracellular matrix glycoprotein tenascin-R. Mol. Cell. Neurosci. 2001, 17:226-240.
210. Saha S., Chant D., Welham J., McGrath J. A systematic review of the prevalence of schizophrenia. PLoS Med. 2005, 2:e141.
211. Schultz S.H., North S.W., Shields C.G. Schizophrenia: a review. Am. Fam. Physician 2007, 75:1821-1829.
212. Schuppel K., Brauer K., Hartig W., Grosche J., Earley B., Leonard B.E., Bruckner G. Perineuronal nets of extracellular matrix around hippocampal interneurons resist destruction by activated microglia in trimethyltin-treated rats. Brain Res. 2002, 958:448-453.
213. Schweizer M., Streit W.J., Muller C.M. Postnatal development and localization of an N-acetylgalactosamine containing glycoconjugate associated with nonpyramidal neurons in cat visual cortex. J. Comp. Neurol. 1993, 329:313-327.
214. Seeger G., Brauer K., Hartig W., Bruckner G. Mapping of perineuronal nets in the rat brain stained by colloidal iron hydroxide histochemistry and lectin cytochemistry. Neuroscience 1994, 58:371-388.
215. Seeger G., Luth H.J., Winkelmann E., Brauer K. Distribution patterns of Wisteria floribunda agglutinin binding sites and parvalbumin-immunoreactive neurons in the human visual cortex: a double-labelling study. J. Hirnforsch. 1996, 37:351-366.
216. Sekirnjak C., Martone M.E., Weiser M., Deerinck T., Bueno E., Rudy B., Ellisman M. Subcellular localization of the K+ channel subunit Kv3.1b in selected rat CNS neurons. Brain Res. 1997, 766:173-187.
217. Selemon L.D., Goldman-Rakic P.S. The reduced neuropil hypothesis: a circuit based model of schizophrenia. Biol. Psychiatry 1999, 45:17-25.
218. Semple D.M., McIntosh A.M., Lawrie S.M. Cannabis as a risk factor for psychosis: systematic review. J. Psychopharmacol. 2005, 19:187-194.
219. Seshadri S., Zeledon M., Sawa A. Synapse-specific contributions in the cortical pathology of schizophrenia. Neurobiol. Dis. 2013, 53:26-35.
220. Shah A., Lodge D.J. A loss of hippocampal perineuronal nets produces deficits in dopamine system function: relevance to the positive symptoms of schizophrenia. Transl. Psychiatry 2013, 3:e215.
221. Singer W. The formation of cooperative cell assemblies in the visual cortex. J. Exp. Biol. 1990, 153:177-197.
222. Snyder S.H. The dopamine hypothesis of schizophrenia: focus on the dopamine receptor. Am. J. Psychiatry 1976, 133:197-202.
223. So H.C., Chen E.Y., Sham P.C. Genetics of schizophrenia spectrum disorders: looking back and peering ahead. Ann. Acad. Med. Singapore 2009, 38:436-444.
224. Soleman S., Filippov M., Dityatev A., Fawcett J. Targeting the neural extracellular matrix in neurological disorders. Neuroscience 2013, 253:194-213.
225. Soleman S., Yip P.K., Duricki D.A., Moon L.D. Delayed treatment with chondroitinase ABC promotes sensorimotor recovery and plasticity after stroke in aged rats. Brain 2012, 135:1210-1223.
226. Song H., Kempermann G., Overstreet Wadiche L., Zhao C., Schinder A.F., Bischofberger J. New neurons in the adult mammalian brain: synaptogenesis and functional integration. J. Neurosci. 2005, 25:10366-10368.
227. Spatazza J., Lee H.H., Di Nardo A.A., Tibaldi L., Joliot A., Hensch T.K., Prochiantz A. Choroid-plexus-derived Otx2 homeoprotein constrains adult cortical plasticity. Cell Rep. 2013, 3:1815-1823.
228. Spencer K.M., Niznikiewicz M.A., Shenton M.E., McCarley R.W. Sensory-evoked gamma oscillations in chronic schizophrenia. Biol. Psychiatry 2008, 63:744-747.
229. Spencer K.M., Niznikiewicz M.A., Nestor P.G., Shenton M.E., McCarley R.W. Left auditory cortex gamma synchronization and auditory hallucination symptoms in schizophrenia. BMC Neurosci. 2009, 10:85.
230. Spreafico R., De Biasi S., Vitellaro-Zuccarello L. The perineuronal net: a weapon for a challenge. J. Hist. Neurosci. 1999, 8:179-185.
231. Stephan K.E., Friston K.J., Frith C.D. Dysconnection in schizophrenia: from abnormal synaptic plasticity to failures of self-monitoring. Schizophr. Bull. 2009, 35:509-527.
232. Stevens J.R. Schizophrenia and multiple sclerosis. Schizophr. Bull. 1988, 14:231-241.
233. Sugiyama S., Di Nardo A.A., Aizawa S., Matsuo I., Volovitch M., Prochiantz A., Hensch T.K. Experience-dependent transfer of Otx2 homeoprotein into the visual cortex activates postnatal plasticity. Cell 2008, 134:508-520.
234. Sun Y., Farzan F., Barr M.S., Kirihara K., Fitzgerald P.B., Light G.A., Daskalakis Z.J. Gamma oscillations in schizophrenia: mechanisms and clinical significance. Brain Res. 2011, 1413:98-114.
235. Sur M., Frost D.O., Hockfield S. Expression of a surface-associated antigen on Y-cells in the cat lateral geniculate nucleus is regulated by visual experience. J. Neurosci. 1988, 8:874-882.
236. Sur M., Nagakura I., Chen N., Sugihara H. Mechanisms of plasticity in the developing and adult visual cortex. Prog. Brain Res. 2013, 207:243-254.
237. Susuki K. Node of Ranvier disruption as a cause of neurological diseases. ASN Neuro 2013, 5:e00118.
238. Suvisaari J.M., Taxell-Lassas V., Pankakoski M., Haukka J.K., Lonnqvist J.K., Hakkinen L.T. Obstetric complications as risk factors for schizophrenia spectrum psychoses in offspring of mothers with psychotic disorder. Schizophr. Bull. 2013, 39:1056-1066.
239. Sweet R.A., Henteleff R.A., Zhang W., Sampson A.R., Lewis D.A. Reduced dendritic spine density in auditory cortex of subjects with schizophrenia. Neuropsychopharmacology 2009, 34:374-389.
240. Sykova E. Glia and volume transmission during physiological and pathological states. J. Neural Transm. 2005, 112:137-147.
241. Sykova E., Mazel T., Simonova Z. Diffusion constraints and neuron-glia interaction during aging. Exp. Gerontol. 1998, 33:837-851.
242. Sykova E., Nicholson C. Diffusion in brain extracellular space. Physiol. Rev. 2008, 88:1277-1340.
243. Takahashi N., Sakurai T., Bozdagi-Gunal O., Dorr N.P., Moy J., Krug L., Gama-Sosa M., Elder G.A., Koch R.J., Walker R.H., Hof P.R., Davis K.L., Buxbaum J.D. Increased expression of receptor phosphotyrosine phosphatase-beta/zeta is associated with molecular, cellular, behavioral and cognitive schizophrenia phenotypes. Transl. Psychiatry 2011, 1:e8.
244. Takahashi N., Sakurai T., Davis K.L., Buxbaum J.D. Linking oligodendrocyte and myelin dysfunction to neurocircuitry abnormalities in schizophrenia. Prog. Neurobiol. 2011, 93:13-24.
245. Takesian A.E., Hensch T.K. Balancing plasticity/stability across brain development. Prog. Brain Res. 2013, 207:3-34.
246. Tews B., Schonig K., Arzt M.E., Clementi S., Rioult-Pedotti M.S., Zemmar A., et al. Synthetic microRNA-mediated downregulation of Nogo-A in transgenic rats reveals its role as regulator of synaptic plasticity and cognitive function. Proc. Natl. Acad. Sci. U.S.A. 2013, 110:6583-6588.
247. Uhlhaas P.J. Dysconnectivity, large-scale networks and neuronal dynamics in schizophrenia. Curr. Opin. Neurobiol. 2013, 23:283-290.
248. Uhlhaas P.J., Roux F., Singer W., Haenschel C., Sireteanu R., Rodriguez E. The development of neural synchrony reflects late maturation and restructuring of functional networks in humans. Proc. Natl. Acad. Sci. U.S.A. 2009, 106:9866-9871.
249. Uhlhaas P.J., Singer W. Abnormal neural oscillations and synchrony in schizophrenia. Nat. Rev. Neurosci. 2010, 11:100-113.
250. Uhlhaas P.J., Singer W. Neural synchrony in brain disorders: relevance for cognitive dysfunctions and pathophysiology. Neuron 2006, 52:155-168.
251. Uhlhaas P.J., Haenschel C., Nikolić D., Singer W. The role of oscillations and synchrony in cortical networks and their putative relevance for the pathophysiology of schizophrenia. Schizophr. Bull. 2008, 34:927-943.
252. Vitellaro-Zuccarello L., De Biasi S., Spreafico R. One hundred years of Golgi's "perineuronal net": history of a denied structure. Ital. J. Neurol. Sci. 1998, 19:249-253.
253. Vo T., Carulli D., Ehlert E.M., Kwok J.C., Dick G., Mecollari V., Moloney E.B., Neufeld G., de Winter F., Fawcett J.W., Verhaagen J. The chemorepulsive axon guidance protein semaphorin3A is a constituent of perineuronal nets in the adult rodent brain. Mol. Cell. Neurosci. 2013, 56:186-200.
254. Volk D.W., Lewis D.A. Impaired prefrontal inhibition in schizophrenia: relevance for cognitive dysfunction. Physiol. Behav. 2002, 77:501-505.
255. Volk D.W., Lewis D.A. Prenatal ontogeny as a susceptibility period for cortical GABA neuron disturbances in schizophrenia. Neuroscience 2013, 248C:154-164.
256. Vuillermot S., Weber L., Feldon J., Meyer U. A longitudinal examination of the neurodevelopmental impact of prenatal immune activation in mice reveals primary defects in dopaminergic development relevant to schizophrenia. J. Neurosci. 2010, 30:1270-1287.
257. Wagoner J.L., Kulesza R.J. Topographical and cellular distribution of perineuronal nets in the human cochlear nucleus. Hear. Res. 2009, 254:42-53.
258. Wang D., Fawcett J. The perineuronal net and the control of CNS plasticity. Cell Tissue Res. 2012, 349:147-160.
259. Wang X., Yi J., Lei J., Pei D. Expression, purification and characterization of recombinant mouse MT5-MMP protein products. FEBS Lett. 1999, 462:261-266.
260. Wegner F., Hartig W., Bringmann A., Grosche J., Wohlfarth K., Zuschratter W., Bruckner G. Diffuse perineuronal nets and modified pyramidal cells immunoreactive for glutamate and the GABA(A) receptor alpha1 subunit form a unique entity in rat cerebral cortex. Exp. Neurol. 2003, 184:705-714.
261. Weinberger D.R. Implications of normal brain development for the pathogenesis of schizophrenia. Arch. Gen. Psychiatry 1987, 44:660-669.
262. Weiser M., Bueno E., Sekirnjak C., Martone M.E., Baker H., Hillman D., Chen S., Thornhill W., Ellisman M., Rudy B. The potassium channel subunit KV3.1b is localized to somatic and axonal membranes of specific populations of CNS neurons. J. Neurosci. 1995, 15:4298-4314.
263. Whalley H.C., Papmeyer M., Sprooten E., Lawrie S.M., Sussmann J.E., McIntosh A.M. Review of functional magnetic resonance imaging studies comparing bipolar disorder and schizophrenia. Bipolar Disord. 2012, 14:411-431.
264. Whiteford H.A., Degenhardt L., Rehm J., Baxter A.J., Ferrari A.J., Erskine H.E., Charlson F.J., Norman R.E., Flaxman A.D., Johns N., Burstein R., Murray C.J., Vos T. Global burden of disease attributable to mental and substance use disorders: findings from the Global Burden of Disease Study 2010. Lancet 2013, 382:1575-1586.
265. Wiesel T.N., Hubel D.H. Single-cell responses in striate cortex of kittens deprived of vision in one eye. J. Neurophysiol. 1963, 26:1003-1017.
266. Wild J.M. Functional neuroanatomy of the sensorimotor control of singing. Ann. N. Y. Acad. Sci. 2004, 1016:438-462.
267. Wilkins A., Majed H., Layfield R., Compston A., Chandran S. Oligodendrocytes promote neuronal survival and axonal length by distinct intracellular mechanisms: a novel role for oligodendrocyte-derived glial cell line-derived neurotrophic factor. J. Neurosci. 2003, 23:4967-4974.
268. Willi R., Schwab M.E. Nogo and Nogo receptor: relevance to schizophrenia?. Neurobiol. Dis. 2013, 54:150-157.
269. Willi R., Weinmann O., Winter C., Klein J., Sohr R., Schnell L., et al. Constitutive genetic deletion of the growth regulator Nogo-A induces schizophrenia-related endophenotypes. J. Neurosci. 2010, 30:556-567.
270. Wintergerst E.S., Vogt Weisenhorn D.M., Rathjen F.G., Riederer B.M., Lambert S., Celio M.R. Temporal and spatial appearance of the membrane cytoskeleton and perineuronal nets in the rat neocortex. Neurosci. Lett. 1996, 209:173-176.
271. Woo T.U., Spencer K., McCarley R.W. Gamma oscillation deficits and the onset and early progression of schizophrenia. Harv. Rev. Psychiatry 2010, 18:173-189.
272. Xu M.Q., Sun W.S., Liu B.X., Feng G.Y., Yu L., Yang L., He G., Sham P., Susser E., St Clair D., He L. Prenatal malnutrition and adult schizophrenia: further evidence from the 1959-1961 Chinese famine. Schizophr. Bull. 2009, 35:568-576.
273. Yamaguchi Y. Lecticans: organizers of the brain extracellular matrix. Cell. Mol. Life Sci.: CMLS 2000, 57:276-289.
274. Yanagi M., Joho R.H., Southcott S.A., Shukla A.A., Ghose S., Tamminga C.A. Kv3.1-containing K channels are reduced in untreated schizophrenia and normalized with antipsychotic drugs. Mol. Psychiatry 2013, 19:573-579.
275. Yang Y., Dieter M.Z., Chen Y., Shertzer H.G., Nebert D.W., Dalton T.P. Initial characterization of the glutamate-cysteine ligase modifier subunit Gclm(-/-) knockout mouse. Novel model system for a severely compromised oxidative stress response. J. Biol. Chem. 2002, 277:49446-49452.
276. Yao J.K., Reddy R. Oxidative stress in schizophrenia: pathogenetic and therapeutic implications. Antioxid. Redox Signal. 2011, 15:1999-2002.
277. Yasuhara O., Akiyama H., McGeer E.G., McGeer P.L. Immunohistochemical localization of hyaluronic acid in rat and human brain. Brain Res. 1994, 635:269-282.
278. Ye Q., Miao Q.L. Experience-dependent development of perineuronal nets and chondroitin sulfate proteoglycan receptors in mouse visual cortex. Matrix Biol. 2013, 32:352-363.
279. Yuan W., Matthews R.T., Sandy J.D., Gottschall P.E. Association between protease-specific proteolytic cleavage of brevican and synaptic loss in the dentate gyrus of kainate-treated rats. Neuroscience 2002, 114:1091-1101.
280. Zaremba S., Guimaraes A., Kalb R.G., Hockfield S. Characterization of an activity-dependent, neuronal surface proteoglycan identified with monoclonal antibody Cat-301. Neuron 1989, 2:1207-1219.
281. Zimmermann D.R., Dours-Zimmermann M.T. Extracellular matrix of the central nervous system: from neglect to challenge. Histochem. Cell Biol. 2008, 130:635-653.
282. Zuo J., Ferguson T.A., Hernandez Y.J., Stetler-Stevenson W.G., Muir D. Neuronal matrix metalloproteinase-2 degrades and inactivates a neurite-inhibiting chondroitin sulfate proteoglycan. J. Neurosci. 1998, 18:5203-5211.